ApoA5 ELISA
- Regulatory Status
- RUO
- Kit size
- 12 x 8
- Method
- ELISA
- Incubation time
- 1 x 1h, 2 x 30min.
- Standard range
- 0.31 - 20 ng/mL
- Specimen / Volumes
- 5µL serum, EDTA-plasma
- Substrate / isotope
- TMB 450nm
Original article #27191.
ApoA5 is a protein with 39kDa molecular weight that was discovered by Pennacchio et al. in 2001. It has been reported that ApoA5 is produced in liver and binds to HDL particles and TG (Triglyceride) rich lipoproteins (CM, VLDL) and exists in blood.
In previous studies, it has been observed that TG levels in the serum of ApoA5 knockout mice is significantly elevated while it is significantly decreased in the serum of the respective knock-in mice. In addition, since then it has been also suggested that ApoA5 deficiency that is caused by ApoA5 gene mutation in human shows severe hypertriglyceridaemia, it has been noted as one of the factors regulating TG metabolism.
This ELISA specifically measures ApoA5 in human blood.
Distributed by IBL International
Our Product Families
Our comprehensive immunoassay portfolio includes a number of specialty diagnostic immunoassays for endocrinology, immunology and autoimmunity, as well as for diagnosis of multiple infectious diseases. We are pioneers and market leaders in saliva diagnostics, with over 40 years of experience supplying a broad portfolio of luminescence- and ELISA-based tests, including our highly acclaimed HMGB1 and MuSK-Ab ELISAs.
And as experts in laboratory automation, we can support our customers with the protocols for open ELISA platforms, such as the Freedom EVOlyzer or Thunderbolt®.
All products are only available for sale to laboratory professionals and may not be available in all countries. Availability and regulatory status may vary across regions depending on local country-specific registration. Please always read and follow the instructions for use.
All of our assays have been designed and manufactured to meet the highest global regulatory requirements and quality standards. Tecan is certified under ISO 9001:2015, ISO 13485:2016 and is audited by a notified body according to Medical Device Single Audit Program (MDSAP).
This is who we are.
As part of the Tecan Group, we have a leading market position in diagnostics and research, with over 40 years of experience in the development, manufacture and supply of enzyme-, radiolabel- and luminescence-based immunoassays.
Our range of high-quality immunoassays is supported by a diverse portfolio of automated solutions, making us the perfect partner for you and your customers.
Happy to help.
At Tecan, we are driven to improve people’s lives and health.